1. Effect of cigarette smoking on serum methylarginine and α-klotho levels.
- Author
-
Onmaz, Mustafa, Demirbas, Nur, Eryavuz Onmaz, Duygu, Kutlu, Ruhusen, and Unlu, Ali
- Abstract
Smoking causes many diseases such as cardiovascular, lung diseases, stroke and premature aging. However, the role of smoking in the pathogenesis of these diseases is unclear. Increasing evidence suggests that methylarginine pathway metabolites and α -klotho may be strong markers for pathologies such as premature aging, endothelial dysfunction, and oxidant damage. Therefore, the study aimed to measure the serum levels of arginine, asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), N-monomethyl- l -arginine (L-NMMA), and α -klotho levels in smokers. This case-control analytical study included 65 smokers and 71 non-smokers. Sociodemographic characteristics, routine biochemistry parameters, Framingham risk scores and Fagerström Nicotine Dependence Test (FTND) were recorded. Serum methylarginine and α -klotho levels were analyzed by tandem mass spectrometry and enzyme-linked immunosorbent assay (ELISA), respectively. Serum ADMA (p < 0.001), L-NMMA (p = 0.024), SDMA (p < 0.001) levels of smokers were higher than non-smokers, and serum α -klotho (p < 0.001) and arginine levels (p < 0.001) were lower. There was a positive correlation between serum ADMA levels with FNDT, age and pack/year in smokers, while there was a negative correlation between klotho levels and age. A positive correlation was found between serum ADMA levels, Framingham risk score and age in non-smokers. Smoking is related to premature aging and is a strong risk factor for various diseases such as cardiovascular, inflammatory, and renal diseases. Elevated serum methylarginine and decreased serum klotho levels were found in smokers. Therefore, our findings suggest that smoking may be involved in the pathogenesis of these diseases by affecting α -klotho and methylarginine-related pathways. • Serum methylarginines were increased in smokers. • Serum α -klotho levels were decreased in smokers. • Serum ADMA and α -klotho were positively correlate with age in smokers. • Serum ADMA levels of the low addicted subjects were significantly lower. • There was a positive correlation between ADMA levels, FTND and smoking pack-years. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF